News Feb 06, 2024 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
News May 18, 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
News Feb 24, 2021 Geneva incubator Fongit launches a new innovation support fund The Fongit incubator has announced the creation of the Innovation Fund in collaboration with the canton of Geneva. This new financing fund is int...
News Feb 09, 2021 Biopôle to welcome three new buildings dedicated to life sciences by 2024 Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and labora...
News Feb 09, 2021 Pharmaceutical and biotech expert ZETA opens a new subsidiary in the canton of Valais ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of...
News Dec 18, 2023 Planzer and Galenica launch Health Supply AG Planzer and Galenica are founding the joint venture Health Supply AG in Villmergen in the canton of Aargau. The aim is to make the transport of m...
News Nov 02, 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
Aktuell Nov 10, 2021 Kollagenmembran von Geistlich Pharma erhält Zulassung in den USA Geistlich Nexo-Gide hat die Zulassung der amerikanischen Aufsichtsbehörde erhalten. Die von Geistlich Pharma entwickelte Kollagenmembran unterstü...
Actualités Mar 08, 2021 Debiopharm signe un contrat de plus de EUR 900 millions avec Merck Debiopharm a accordé une licence mondiale exclusive au géant pharmaceutique Merck pour le développement et la commercialisation de son médicament...
ニュース Feb 10, 2021 バイオポールがライフサイエンス特化の3施設を2024年までにオープン スイス・イノベーション・パーク・ネットワーク・ウエスト EPFLに属するバイオポールが、3棟の新施設建設で拡大を続けています。新施設はライフサイエンス分野に特化し、2024年までに関連企業の入居用に23万㎡のオフィススペースと研究施設が整備される予定です。
News Jul 06, 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News Nov 30, 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
News Nov 10, 2021 Geistlich Pharma’s collagen membrane authorized for use in the USA The Geistlich Nexo-Gide has obtained clearance from the US Food and Drug Administration (FDA). The collagen membrane developed by Geistlich Pharm...
News May 11, 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...